[Form 4] DarioHealth Corp. Insider Trading Activity

Rhea-AI Filing Summary

Steven Nelson, President and CCO of DarioHealth Corp. (DRIO), reported a non-derivative acquisition on 09/11/2025 of 30,000 restricted shares granted at $0. The award vests on the last day of the second-year anniversary after the grant date. Following the transaction and a 20-for-1 reverse stock split effected on August 28, 2025, Nelson beneficially owns 34,750 shares. The Form 4 was signed on 09/15/2025.

Positive

• Officer alignment: President and CCO received a restricted share award, aligning his compensation with shareholder outcomes
• Clear vesting terms: Award vests on the last day of the second-year anniversary after grant, providing multi-year retention incentive
• Post-split ownership disclosed: Beneficial ownership figure reflects the 20-for-1 reverse stock split effected August 28, 2025

Negative

• None.

Insights

Financial Analyst

TL;DR: Senior officer received a restricted share award of 30,000 shares, vesting over two years; post-split beneficial ownership is 34,750 shares.

The filing documents a standard restricted share grant to an executive at no cash cost, which aligns management compensation with future performance through a multi-year vesting schedule. The post-transaction beneficial ownership number explicitly reflects a 20-for-1 reverse split enacted on August 28, 2025. No cash proceeds or derivative transactions are reported.

Corporate Governance Expert

TL;DR: This is a routine insider grant with a defined vesting date; disclosure appears complete for the transaction reported.

The Form 4 identifies the reporting person, role, transaction date, award amount, vesting condition, and the effect of a recent reverse split. The signature and dates are present. The nature of the award and the explicit vesting schedule are disclosed consistent with Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Nelson Steven Charles

(Last) (First) (Middle)

322 W 57TH STREET, #33B

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CCO

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025(1)		A		30,000	A	$0	34,750(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

2. The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

	/s/ Steven Nelson	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Steven Nelson report on Form 4 for DRIO?

He reported the acquisition of 30,000 restricted shares on 09/11/2025 at a reported price of $0.

When do the restricted shares reported by the DRIO officer vest?

The restricted share award vests on the last day of the second-year anniversary after the grant date.

How many DRIO shares does the reporting person beneficially own after the transaction?

The Form 4 lists 34,750 shares beneficially owned following the reported transaction, reflecting the reverse split.

Was there a stock split affecting the reported DRIO ownership?

Yes. The filing states a 20-for-1 reverse stock split was effected on August 28, 2025, and the ownership number reflects that split.

When was the Form 4 signed and filed by the reporting person?

The Form 4 shows a signature dated 09/15/2025.